Episode
Findings from the 2025 IDF Diabetes Atlas with Felix Teufel, Teplizumab & Type 1 Diabetes Therapies with Chantal Mathieu, and more!
- Podcast
- Diabetes Care "On Air"
- Published
- Mar 2, 2026
- Duration seconds
- 3705
- Processing state
not_requested- Canonical source
- https://diabetescareonair.libsyn.com/site
Actions
POST https://stenobird.com/v1/public/podcasts/diabetes-care-on-air-5983699/episodes/findings-from-the-2025-idf-diabetes-atlas-with-felix-teufel-teplizumab-type-1-diabetes-therapies-with-chantal-mathieu-and-more/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/diabetes-care-on-air-5983699/findings-from-the-2025-idf-diabetes-atlas-with-felix-teufel-teplizumab-type-1-diabetes-therapies-with-chantal-mathieu-and-more.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Welcome to the latest episode (March 2026) of Diabetes Care "On Air"—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the March 2026 issue of Diabetes Care and beyond. 5:45 Alice welcomes Felix Teufel , MD and PhD candidate in global health and development at Emory University's Rollins School of Public Health. He is corresponding author on the article, "Global, Regional, and National Estimates of Undiagnosed Diabetes in Adults: Findings From the 2025 IDF Diabetes Atlas," available for free at doi.org/10.2337/dc25-2583 . 18:25 Mike speaks with Chantal Mathieu , MD, PhD, professor of medicine at the Katholieke Universiteit Leuven in Belgium and chair of endocrinology at the University Hospital Gasthuisberg Leuven. She is corresponding author on the article "Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab," available for free at doi.org/10.2337/dci25-0066 . 45:55 In this month's "Diabetes Care Rapid Exchange" segment, Alice and Mike wrap up the episode by reviewing several interesting articles in the March 2025 issue of Diabetes Care. Studies highlighted in this segment include: Jacobsen et al. Going From Stage 2 to Stage 3 Type 1 Diabetes—Does Not Matter How You Got Here doi.org/10.2337/dci25-0118 Kuo et al. The Effect of Midpregnancy Screening for Gestational Diabetes Mellitus on Pregnancy Outcomes: The TESGO Randomized Controlled Trial doi.org/10.2337/dc25-0084 Moscoso-Vasquez et al. Safety and Feasibility of a Fully Automated Insulin Delivery System: FCL@Home, a Multicenter Randomized Clinical Trial in Individuals With Type 1 Diabetes doi.org/10.2337/dc25-1526 Di Marco et al. Metabolic Factors…